Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
the Faculty of Science and Engineering, which is home to five academic Schools, where role holders will be hosted within the faculty associated with the degree apprenticeship operations at London City Institute
-
The London School of Hygiene & Tropical Medicine (LSHTM) is one of the world’s leading public health universities. Our mission is to improve health and health equity in the UK and worldwide; working
-
Cooper) and have close links to the NIHR DeNPRU (Dementia and Neurodegenerative diseases policy research unit). About You The post holder is responsible for providing research support to the INSTILLED
-
, Asylum and Nationality Act 2006. Full-Time, Permanent The Role The CoSTARNational R&D Lab, led by Royal Holloway, University of London, is seeking a strategic, driven, and collaborative Head of Programme
-
Careers Service. Royal Holloway’s RH2030s strategy sets a bold direction for delivering careers education that is inclusive, industry-connected, and future-focused. In response, the Careers Service is
-
Sciences. This is a unique opportunity for an individual with a keen interest in growing their research programme in one of the most inclusive universities in the UK. About You The successful candidate will
-
The University of London The University of London is the UK’s largest provider of international distance and online learning and the convenor of a federation of 17 London-based universities, many
-
responsibilities within the team. This is the perfect environment for those wishing to develop their career as an ECC nurse, with exciting opportunities available. Working hours will be 35 hours every other weekend
-
– a £43.6M national programme co-led by Queen Mary University of London. PharosAI is set to revolutionise AI-powered cancer care, accelerating the development of breakthrough therapies, advancing
-
-led by Queen Mary University of London. PharosAI is set to revolutionise AI-powered cancer care, accelerating the development of breakthrough therapies, advancing clinical applications, and improving